General Information of the Compound
Compound ID
CP0513850
Compound Name
1-[(3-chlorophenyl)methyl]-4-piperazin-1-ylimidazo[4,5-c]pyridine
    Show/Hide
Structure
Formula
C17H18ClN5
Molecular Weight
327.819
Canonical SMILES
Clc1cccc(Cn2cnc3c(nccc23)N2CCNCC2)c1
    Show/Hide
InChI
InChI=1S/C17H18ClN5/c18-14-3-1-2-13(10-14)11-23-12-21-16-15(23)4-5-20-17(16)22-8-6-19-7-9-22/h1-5,10,12,19H,6-9,11H2
    Show/Hide
InChIKey
VJCINCOJWWIFOC-UHFFFAOYSA-N
Physicochemical Property
logP
2.5426
Rotatable Bonds
3
Heavy Atom Count
23
Polar Areas
45.98
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 145955674
ChEMBL ID
CHEMBL4166372
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 320 nM
   TI
   LI
   LO
   TS